Med’s Industry
Amgen announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRA™ (tarlatamab-dlle) for the treatment of adult patients with e...
May 17, 2024 | News
“Approval of the Axonics recharge-free system is welcome news for Australians with bladder and bowel dysfunction,” said...
May 17, 2024 | News
The Vantive mission, "Extending Lives, Expanding Possibilities," will guide and inspire the proposed company, which will focus on vital organ therapies for...
May 16, 2024 | News
The Applied Biosystems™ Axiom™ BloodGenomiX™ Array and Software provide a high-throughput solution for more precise blood matching resear...
May 16, 2024 | News
The planned close to 6,000 sqft facility at Royal Square in Novena is expected to commence operations by November 2024 and will nearly double AsiaMedic&r...
May 15, 2024 | News
A&D Company, Limited has entered into a US$1M investment agreement with Aevice Health The collaboration is geared towards jointly expand...
May 15, 2024 | News
Fujitsu announced the development of explainable AI technology that automatically draws on data in multiple formats, including text, images, and nume...
May 13, 2024 | News
-- The companies share design of global Phase 3 trial, iMMagine-3; will evaluate anito-cel in patients exposed to both an immunomodulatory (lMi...
May 10, 2024 | News
The Global Health Innovative Technology (GHIT) Fund announced a substantial investment of approximately JPY 1.64 billion (USD 10.8 million) dedicated...
May 09, 2024 | News
Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, announced that the U...
May 07, 2024 | News
The agreement aims to supply ImmunityBio with Bacillus Calmette-Guerin (BCG), a critical component in cancer treatment. Under the collaboration, the ...
May 06, 2024 | News
GE HealthCare unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, whic...
May 06, 2024 | News
HanAll has initiated a Phase III VELOS-4 study to evaluate the efficacy and safety of tanfanercept in dry eye based on the findings from the previous Pha...
May 06, 2024 | News
For organ transplant recipients, life post-transplant involves a delicate balance between invasive monitoring and immunosuppression to reduce the risk of r...
May 03, 2024 | News
Most Read
Bio Jobs
News
Editor Picks